Brinzolamide

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 456 publications

Dapagliflozin embedded polymeric nanomicelles for enhanced ocular drug delivery: A promising strategy for glaucoma therapy.

Dapagliflozin embedded polymeric nanomicelles for enhanced ocular drug delivery: A promising strategy for glaucoma therapy.

Journal: International journal of pharmaceutics

Published: April 27, 2026

Corrigendum to "Brinzolamide encapsulated β-cyclodextrin-chondroitin sulfate nanocomplexes anchored chitosan/polycaprolactone nanofibers as an ocular insert for glaucoma treatment" [Mater. Today Bio 34 (2025) 102179].

Corrigendum to "Brinzolamide encapsulated β-cyclodextrin-chondroitin sulfate nanocomplexes anchored chitosan/polycaprolactone nanofibers as an ocular insert for glaucoma treatment" [Mater. Today Bio 34 (2025) 102179].

Journal: Materials today. Bio

Published: April 02, 2026

Alternate day vs daily topical brinzolamide for the treatment of cystic maculopathy in inherited rod cone retinal degenerations.

Alternate day vs daily topical brinzolamide for the treatment of cystic maculopathy in inherited rod cone retinal degenerations.

Journal: Ophthalmic genetics

Published: March 31, 2026

Discovery of anti-glaucoma agents with dual hCA II inhibitory and nitric oxide-releasing activity and their neuroprotective effects.

Discovery of anti-glaucoma agents with dual hCA II inhibitory and nitric oxide-releasing activity and their neuroprotective effects.

Journal: European journal of medicinal chemistry

Published: February 13, 2026

Allergic Contact Dermatitis From Dorzolamide Without Cross-Reactivity to Brinzolamide.

Allergic Contact Dermatitis From Dorzolamide Without Cross-Reactivity to Brinzolamide.

Journal: Contact dermatitis

Published: January 26, 2026

Discovery of Novel NO-Donor Containing hCA II Inhibitors with Retinal Ganglion Cell-Protective Effects for the Efficient Treatment of Glaucoma.

Discovery of Novel NO-Donor Containing hCA II Inhibitors with Retinal Ganglion Cell-Protective Effects for the Efficient Treatment of Glaucoma.

Journal: Journal of medicinal chemistry

Published: December 18, 2025

Treatment Persistence with Combination Eye Drops for Glaucoma: A Longitudinal Analysis Using Japanese Medical Claims Data.

Treatment Persistence with Combination Eye Drops for Glaucoma: A Longitudinal Analysis Using Japanese Medical Claims Data.

Journal: Ophthalmology and therapy

Published: December 09, 2025

Stressing the limits of capillary blood in anti-doping analysis: perspectives on alkylamine-like stimulants and carbonic anhydrase II inhibitors in result management.

Stressing the limits of capillary blood in anti-doping analysis: perspectives on alkylamine-like stimulants and carbonic anhydrase II inhibitors in result management.

Journal: Frontiers in sports and active living

Published: November 27, 2025

Depression and Anxiety After Topical Carbonic Anhydrase Inhibitors.

Depression and Anxiety After Topical Carbonic Anhydrase Inhibitors.

Journal: Ophthalmology science

Published: November 10, 2025

Case Report: Carbonic anhydrase inhibitor brinzolamide dramatically improved the morphology and also function of a patient with RS1 mutation.

Case Report: Carbonic anhydrase inhibitor brinzolamide dramatically improved the morphology and also function of a patient with RS1 mutation.

Journal: Frontiers in pharmacology

Published: September 16, 2025

Ocular administration of brinzolamide leading to Stevens-Johnson syndrome/toxic epidermal necrolysis overlap: A case report and review.

Ocular administration of brinzolamide leading to Stevens-Johnson syndrome/toxic epidermal necrolysis overlap: A case report and review.

Journal: Medicine

Published: August 05, 2025

Ophthalmic-targeted brinzolamide-laden cubosomal solid lipid nano-vesicular system (Cube-SLNV): design, development, and in vitro and ex vivo characterization.

Ophthalmic-targeted brinzolamide-laden cubosomal solid lipid nano-vesicular system (Cube-SLNV): design, development, and in vitro and ex vivo characterization.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: July 24, 2025

Showing 1-12 of 456

Last Updated: 06/30/2026